Under construction – not a live service
Sign in
Not yet taking people in EgyptPhase 2

Rutin and Vitamin C for Fatty Liver Disease Linked to Metabolic Problems

Tests rutin with vitamin C versus vitamin C alone in adults with fatty liver.

Plain-language title generated from the registry record
Registry title: Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Key facts

Where
Cairo, EgyptSee the site
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07310407, who can take part

Where in Egypt

  • National Hepatology and Tropical Medicine Research Institute (NHTMRI)Cairo, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ain Shams University
Trial code
NCT07310407
Record updated
30 December 2025
Original description
evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLDRead full original descriptionShow less

Evaluation of the Effect of Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLD

Inclusion: Confirmed diagnosis of Metabolic-Associated Steatotic Liver Disease (MASLD).

Exclusion: Drugs: Tamoxifen, Valproic acid, Amiodarone, Methotrexate, steroids and immunosuppressive agents, oral contraceptive pills, or drugs that can affect liver profile; HCV infection; HBV infection; Patients with a history of significant alcohol consumption; Autoimmune hepatitis; Celiac disease (CD); Wilson's disease (WD); Haemochromatosis; Hypo or hyper thyroidism; Bypass surgeries; TPN (Total Parenteral Nutrition); Pregnant individuals or patients planning to become pregnant.

ClinicalTrials.gov NCT07310407